医学
暴露前预防
人类免疫缺陷病毒(HIV)
阴道环
替诺福韦
男性包皮环切术
传输(电信)
重症监护医学
病毒学
环境卫生
和男人发生性关系的男人
梅毒
卫生服务
人口
研究方法
计划生育
电气工程
工程类
作者
Geoffroy Liégeon,Constance Delaugerre,Jean‐Michel Molina
标识
DOI:10.1016/j.idc.2024.04.003
摘要
Pre-exposure prophylaxis (PrEP) of human immunodeficiency virus (HIV) represents the most significant breakthrough in the HIV prevention field over the past decade. PrEP is an effective strategy in preventing the transmission of HIV across all populations, providing high adherence. The current PrEP options include oral daily and on-demand tenofovir-based regimens, long-acting injections of cabotegravir, and a 1-month dapivirine vaginal ring. As a component of a multifaceted prevention approach, extensive deployment of PrEP holds the promise to significantly reduce the global HIV epidemic. Nonetheless, barriers still exist in terms of uptake, adherence, and persistence, while disparities in PrEP accessibility remain a concern.
科研通智能强力驱动
Strongly Powered by AbleSci AI